Nomad Foods Reports Second Quarter 2025 Financial Results
Retail sell-out growth accelerated through mid-June and market share improved in the quarter
Unfavorable weather presented unforeseen net sales headwinds
Lowering guidance given first half shortfall and to increase flexibility to absorb other unforeseen shortfalls
WOKING,
Key operating metrics and financial performance for the second quarter 2025, when compared to the second quarter 2024, include:
- Revenue decreased 0.8% to €747 million
- Organic revenue declined 1.1% with a volume decline of 1.0%
- Adjusted gross margin contracted 310 bps
- Adjusted EBITDA decreased 7.2% to €129 million
- Adjusted EPS decreased 9.1% to €0.40
Management Comments
Stéfan Descheemaeker,
Second Quarter of 2025 results compared to the Second Quarter of 2024
- Revenue decreased 0.8% to €747 million. Organic revenue decreased by 1.1% and was driven by a volume decline of 1.0% and price/mix decline of 0.1%.
- Adjusted gross profit decreased 10.8% to €208 million. Adjusted gross margin decreased 310 basis points to 27.8% due primarily to supply chain inflation headwinds.
- Adjusted operating expenses decreased 11.4% to €103 million due to a double-digit contraction in overhead costs in the quarter. Advertising and Promotion was down modestly YoY in the quarter and has risen 5% through the first half of the year.
- Adjusted EBITDA decreased 7.2% to €129 million due to the aforementioned factors and Adjusted Profit for the period decreased 16% to €61 million.
- Adjusted EPS decreased by €0.04 to €0.40 reflecting the decrease in Adjusted Profit for the period and fewer shares outstanding. Diluted EPS decreased €0.06 to €0.37.
First Six Months of 2025 results compared to the First Six Months of 2024
- Revenue decreased 1.9% to €1,507 million. Organic revenue decreased by 2.4% and was driven by a volume decline of 2.3%. and a decline in price/mix of 0.1%.
- Adjusted gross profit decreased 5.5% to €419 million. Adjusted gross margin decreased 110 basis points to 27.8%, due to supply chain inflation headwinds, partially offset with supply chain productivity and the lapping of inventory revaluation headwinds in the prior year.
- Adjusted operating expenses decreased 4.2% to €219 million as overhead cost reductions more than offset a mid single-digit year-to-date increase in Advertising and Promotion expense.
- Adjusted EBITDA decreased 4.7% to €249 million due to the aforementioned factors. Adjusted Profit for the period decreased 14% to €114 million.
- Adjusted EPS decreased by €0.07 to €0.74 reflecting the decrease in Adjusted Profit for the period and fewer shares outstanding. Diluted EPS decreased €0.07 to €0.58.
2025 Guidance
The Company is lowering its full-year guidance given weaker-than-expected first half results and to enhance its ability to absorb other unforeseen disruptions in the second half of the year, were they to occur. Full year organic revenue is now expected to be flat to -2% versus the prior expectation of a 0%-2% year-on-year change. The full year Adjusted EBITDA guidance range is now -3% to -7% year-on-year versus its prior outlook of 0%-2% year-on-year. Adjusted EPS is now expected to be in a range of €1.64 to €1.76 versus the previous range of €1.82-€1.89. Based on USD/EUR exchange rate as of
Conference Call and Webcast
A pre-recorded management discussion of
Enquiries
Investor Relations Contact
investorrelations@nomadfoods.com
Media Contact
Oliver.Thomas@nomadfoods.com
About
Non-IFRS Financial Information
Adjusted financial information for the three and six months ended
Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance.
Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, net financing income/(cost) on amendment of terms of debt, interest cost on tax relating to legacy tax audits, foreign exchange translation gains/(losses), foreign exchange gains/(losses) on derivatives, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit for the period provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EPS is defined as diluted earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, net financing income/(cost) on amendment of terms of debt, interest cost on tax relating to legacy tax audits, foreign exchange translation gains/(losses), foreign exchange gains/(losses) on derivatives, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three and six months ended
Adjusted Gross Profit and adjusted gross margin exclude accelerated depreciation associated with restructuring programs within cost of goods sold.
Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.
Adjusted Free Cash Flow – Adjusted free cash flow is the amount of cash generated from operating activities less cash flows related to exceptional items (as described above), non-operating M&A related costs and working capital movements on employer taxes associated with share based payment awards, plus capital expenditure (on property, plant and equipment and intangible assets), net interest paid, proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and payments of lease liabilities. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives.
Cash flow conversion is Adjusted Free Cash Flow as a percentage of Adjusted Profit for the period.
Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of
Please see on pages 9 to 14, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The
Company is unable to reconcile, without unreasonable efforts, Organic Growth, Adjusted EBITDA and Adjusted EPS guidance to the most directly comparable IFRS measure.
Nomad Foods Limited As Reported Condensed Consolidated Interim Statements of Profit or Loss (unaudited)
Three months ended
|
|||
|
Three months ended |
|
Three months ended |
|
€m |
|
€m |
Revenue |
746.9 |
|
753.1 |
Cost of sales |
(540.6) |
|
(520.3) |
Gross profit |
206.3 |
|
232.8 |
Other operating expenses |
(103.9) |
|
(119.3) |
Exceptional items |
(14.9) |
|
(12.4) |
Operating profit |
87.5 |
|
101.1 |
Finance income |
13.6 |
|
18.0 |
Finance costs |
(30.5) |
|
(31.4) |
Net financing costs |
(16.9) |
|
(13.4) |
Profit before tax |
70.6 |
|
87.7 |
Taxation |
(13.5) |
|
(16.8) |
Profit for the period |
57.1 |
|
70.9 |
|
|
|
|
Basic and diluted earnings per share in € |
0.37 |
|
0.43 |
Statements of Profit or Loss (unaudited)
Six months ended
|
|||
|
Six months ended |
|
Six months ended |
|
€m |
|
€m |
Revenue |
1,507.0 |
|
1,536.8 |
Cost of sales |
(1,089.1) |
|
(1,093.1) |
Gross profit |
417.9 |
|
443.7 |
Other operating expenses |
(224.6) |
|
(234.7) |
Exceptional items |
(32.0) |
|
(35.9) |
Operating profit |
161.3 |
|
173.1 |
Finance income |
10.5 |
|
23.9 |
Finance costs |
(61.5) |
|
(67.4) |
Net financing costs |
(51.0) |
|
(43.5) |
Profit before tax |
110.3 |
|
129.6 |
Taxation |
(20.5) |
|
(24.2) |
Profit for the period |
89.8 |
|
105.4 |
|
|
|
|
Basic earnings per share in € |
0.59 |
|
0.65 |
Diluted earnings per share in € |
0.58 |
|
0.65 |
Nomad Foods Limited As Reported Condensed Consolidated Interim Statements of Financial Position
As at
|
|||
|
As at |
|
As at |
|
€m |
|
€m |
Non-current assets |
|
|
|
|
2,105.1 |
|
2,106.1 |
Intangible assets |
2,474.4 |
|
2,472.9 |
Property, plant and equipment |
585.6 |
|
591.1 |
Other non-current assets |
7.3 |
|
8.6 |
Derivative financial instruments |
1.9 |
|
4.3 |
Deferred tax assets |
11.7 |
|
14.7 |
Total non-current assets |
5,186.0 |
|
5,197.7 |
Current assets |
|
|
|
Cash and cash equivalents |
266.6 |
|
403.3 |
Inventories |
461.1 |
|
441.5 |
Trade and other receivables |
423.3 |
|
334.6 |
Current tax receivable |
35.1 |
|
37.6 |
Derivative financial instruments |
4.0 |
|
16.9 |
Total current assets |
1,190.1 |
|
1,233.9 |
Total assets |
6,376.1 |
|
6,431.6 |
Current liabilities |
|
|
|
Trade and other payables |
870.5 |
|
829.1 |
Current tax payable |
213.3 |
|
226.7 |
Provisions |
27.3 |
|
27.1 |
Loans and borrowings |
29.9 |
|
26.0 |
Derivative financial instruments |
21.7 |
|
14.4 |
Total current liabilities |
1,162.7 |
|
1,123.3 |
Non-current liabilities |
|
|
|
Loans and borrowings |
2,072.5 |
|
2,151.4 |
Employee benefits |
149.2 |
|
152.1 |
Other non-current liabilities |
0.3 |
|
0.5 |
Provisions |
2.6 |
|
2.7 |
Derivative financial instruments |
141.8 |
|
46.4 |
Deferred tax liabilities |
283.3 |
|
292.7 |
Total non-current liabilities |
2,649.7 |
|
2,645.8 |
Total liabilities |
3,812.4 |
|
3,769.1 |
Net assets |
2,563.7 |
|
2,662.5 |
Equity attributable to equity holders |
|
|
|
Share capital and capital reserve |
1,227.7 |
|
1,316.4 |
Share-based compensation reserve |
13.2 |
|
26.2 |
Translation reserve |
111.5 |
|
135.3 |
Other reserves |
(32.6) |
|
(14.9) |
Retained earnings |
1,243.9 |
|
1,199.5 |
Total equity |
2,563.7 |
|
2,662.5 |
Nomad Foods Limited As Reported Condensed Consolidated Interim Statements of Cash Flows (unaudited)
For the six months ended
|
|||
|
For the six months ended |
|
For the six months ended |
|
€m |
|
€m |
Cash flows from operating activities |
|
|
|
Profit for the period |
89.8 |
|
105.4 |
Adjustments for: |
|
|
|
Exceptional items |
32.0 |
|
35.9 |
Share based payment expense |
4.1 |
|
5.0 |
Depreciation and amortization |
50.3 |
|
46.3 |
Loss on disposal of property, plant and equipment |
0.4 |
|
0.4 |
Net finance costs |
51.0 |
|
43.5 |
Taxation |
20.5 |
|
24.2 |
Operating cash flow before changes in working capital, provisions and exceptional items |
248.1 |
|
260.7 |
(Increase)/decrease in inventories |
(27.9) |
|
14.5 |
Increase in trade and other receivables |
(91.0) |
|
(81.1) |
Increase/(decrease) in trade and other payables |
56.4 |
|
(22.4) |
Decrease in employee benefits and other provisions |
(1.0) |
|
(0.6) |
Cash generated from operations before tax and exceptional items |
184.6 |
|
171.1 |
Payments relating to exceptional items |
(30.8) |
|
(40.8) |
Tax paid |
(33.6) |
|
(19.0) |
Net cash generated from operating activities |
120.2 |
|
111.3 |
Cash flows from investing activities |
|
|
|
Purchase of property, plant and equipment and intangibles |
(37.1) |
|
(39.9) |
Interest received |
2.4 |
|
3.7 |
Net cash used in investing activities |
(34.7) |
|
(36.2) |
Cash flows from financing activities |
|
|
|
Repurchase of ordinary shares |
(100.5) |
|
(19.2) |
Payments related to shares withheld for taxes |
(6.6) |
|
(4.6) |
Payment of lease liabilities |
(17.0) |
|
(14.6) |
Dividends paid |
(48.4) |
|
(45.1) |
Payment of financing fees |
(0.2) |
|
(1.7) |
Interest paid |
(51.6) |
|
(60.8) |
Net cash used in financing activities |
(224.3) |
|
(146.0) |
Net decrease in cash and cash equivalents |
(138.8) |
|
(70.9) |
Cash and cash equivalents at beginning of period |
403.3 |
|
399.7 |
Effect of exchange rate fluctuations |
2.1 |
|
(1.1) |
Cash and cash equivalents at end of period |
266.6 |
|
327.7 |
Reconciliation of Non-IFRS Financial Measures
(In € millions, except per share data)
The following table reconciles adjusted financial information for the three months ended
Adjusted Statement of Profit or Loss (unaudited)
Three Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
746.9 |
|
— |
|
|
|
746.9 |
Cost of sales |
(540.6) |
|
1.4 |
|
(a) |
|
(539.2) |
Gross profit |
206.3 |
|
1.4 |
|
|
|
207.7 |
Other operating expenses |
(103.9) |
|
0.6 |
|
(b) |
|
(103.3) |
Exceptional items |
(14.9) |
|
14.9 |
|
(c) |
|
— |
Operating profit |
87.5 |
|
16.9 |
|
|
|
104.4 |
Finance income |
13.6 |
|
(12.4) |
|
|
|
1.2 |
Finance costs |
(30.5) |
|
— |
|
|
|
(30.5) |
Net financing costs |
(16.9) |
|
(12.4) |
|
(d) |
|
(29.3) |
Profit before tax |
70.6 |
|
4.5 |
|
|
|
75.1 |
Taxation |
(13.5) |
|
(1.1) |
|
(e) |
|
(14.6) |
Profit for the period |
57.1 |
|
3.4 |
|
|
|
60.5 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
152.4 |
|
|
|
|
|
152.4 |
Basic earnings per share |
0.37 |
|
|
|
|
|
0.40 |
Weighted average shares outstanding in millions - diluted |
152.6 |
|
|
|
|
|
152.6 |
Diluted earnings per share |
0.37 |
|
|
|
|
|
0.40 |
|
|
(a) |
Represents elimination of €1.4 million of accelerated depreciation related to assets impacted by the planned closure of a factory in |
(b) |
Represents share based payment charge including employer payroll taxes of €0.4 million and non-operating M&A transaction costs of €0.2 million. |
(c) |
Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(d) |
Represents elimination of €12.4 million of foreign exchange translation gains. |
(e) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the three months ended
Adjusted Statement of Profit or Loss (unaudited)
Three Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
753.1 |
|
— |
|
|
|
753.1 |
Cost of sales |
(520.3) |
|
— |
|
|
|
(520.3) |
Gross profit |
232.8 |
|
— |
|
|
|
232.8 |
Other operating expenses |
(119.3) |
|
2.7 |
|
(a) |
|
(116.6) |
Exceptional items |
(12.4) |
|
12.4 |
|
(b) |
|
— |
Operating profit |
101.1 |
|
15.1 |
|
|
|
116.2 |
Finance income |
18.0 |
|
(16.0) |
|
|
|
2.0 |
Finance costs |
(31.4) |
|
2.3 |
|
|
|
(29.1) |
Net financing costs |
(13.4) |
|
(13.7) |
|
(c) |
|
(27.1) |
Profit before tax |
87.7 |
|
1.4 |
|
|
|
89.1 |
Taxation |
(16.8) |
|
(0.5) |
|
(d) |
|
(17.3) |
Profit for the period |
70.9 |
|
0.9 |
|
|
|
71.8 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
163.0 |
|
|
|
|
|
163.0 |
Basic earnings per share |
0.43 |
|
|
|
|
|
0.44 |
Weighted average shares outstanding in millions - diluted |
163.1 |
|
|
|
|
|
163.1 |
Diluted earnings per share |
0.43 |
|
|
|
|
|
0.44 |
|
|
(a) |
Represents share based payment charge including employer payroll taxes of €2.4 million and non-operating M&A transaction costs of €0.3 million. |
(b) |
Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(c) |
Represents elimination of €10.3 million of net gains on repricing of debt, a one-time €5.7 million gain from reversal of the impairment of a short-term investment which was made with surplus cash as part of our cash management activities, €2.1 million of foreign exchange translation losses and €0.2 million of losses on derivatives. |
(d) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the six months ended
Adjusted Statement of Profit or Loss (unaudited)
Six Months Ended
|
|||||||
€ in millions, except per share data |
As reported for |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
1,507.0 |
|
— |
|
|
|
1,507.0 |
Cost of sales |
(1,089.1) |
|
1.4 |
|
(a) |
|
(1,087.7) |
Gross profit |
417.9 |
|
1.4 |
|
|
|
419.3 |
Other operating expenses |
(224.6) |
|
5.8 |
|
(b) |
|
(218.8) |
Exceptional items |
(32.0) |
|
32.0 |
|
(c) |
|
— |
Operating profit |
161.3 |
|
39.2 |
|
|
|
200.5 |
Finance income |
10.5 |
|
(7.8) |
|
|
|
2.7 |
Finance costs |
(61.5) |
|
— |
|
|
|
(61.5) |
Net financing costs |
(51.0) |
|
(7.8) |
|
(d) |
|
(58.8) |
Profit before tax |
110.3 |
|
31.4 |
|
|
|
141.7 |
Taxation |
(20.5) |
|
(7.1) |
|
(e) |
|
(27.6) |
Profit for the period |
89.8 |
|
24.3 |
|
|
|
114.1 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
153.5 |
|
|
|
|
|
153.5 |
Basic earnings per share |
0.59 |
|
|
|
|
|
0.74 |
Weighted average shares outstanding in millions - diluted |
153.7 |
|
|
|
|
|
153.7 |
Diluted earnings per share |
0.58 |
|
|
|
|
|
0.74 |
|
|
(a) |
Represents elimination of €1.4 million of incremental depreciation related to assets impacted by the planned closure of a factory in |
(b) |
Represents share based payment charge including employer payroll taxes of €5.3 million and non-operating M&A transaction costs of €0.5 million. |
(c) |
Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(d) |
Represents elimination of €7.8 million of foreign exchange translation gains. |
(e) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the six months ended
Adjusted Statement of Profit or Loss (unaudited)
Six Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for |
Revenue |
1,536.8 |
|
— |
|
|
|
1,536.8 |
Cost of sales |
(1,093.1) |
|
— |
|
|
|
(1,093.1) |
Gross profit |
443.7 |
|
— |
|
|
|
443.7 |
Other operating expenses |
(234.7) |
|
6.4 |
|
(a) |
|
(228.3) |
Exceptional items |
(35.9) |
|
35.9 |
|
(b) |
|
— |
Operating profit |
173.1 |
|
42.3 |
|
|
|
215.4 |
Finance income |
23.9 |
|
(20.1) |
|
|
|
3.8 |
Finance costs |
(67.4) |
|
12.7 |
|
|
|
(54.7) |
Net financing costs |
(43.5) |
|
(7.4) |
|
(c) |
|
(50.9) |
Profit before tax |
129.6 |
|
34.9 |
|
|
|
164.5 |
Taxation |
(24.2) |
|
(7.9) |
|
(d) |
|
(32.1) |
Profit for the period |
105.4 |
|
27.0 |
|
|
|
132.4 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
163.1 |
|
|
|
|
|
163.1 |
Basic earnings per share |
0.65 |
|
|
|
|
|
0.81 |
Weighted average shares outstanding in millions - diluted |
163.2 |
|
|
|
|
|
163.2 |
Diluted earnings per share |
0.65 |
|
|
|
|
|
0.81 |
|
|
(a) |
Represents share based payment expense including employer payroll taxes of €5.8 million and non-operating M&A transaction costs of €0.6 million. |
(b) |
Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(c) |
Represents elimination of €14.4 million of net gains on repricing of debt, a one-time €5.7 million gain from the reversal of an impairment of a short-term investment which was made with surplus cash as part of our cash management activities, €12.3 million of foreign exchange translation losses and €0.4 million of losses on derivatives. |
(d) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted EBITDA to the reported results of Adjusted EBITDA (unaudited)
|
|||||||
|
Three months ended |
|
Six months ended |
||||
€ in millions |
|
|
|
|
|
|
|
Profit for the period |
57.1 |
|
70.9 |
|
89.8 |
|
105.4 |
Taxation |
13.5 |
|
16.8 |
|
20.5 |
|
24.2 |
Net financing costs |
16.9 |
|
13.4 |
|
51.0 |
|
43.5 |
Depreciation & amortization |
26.3 |
|
23.2 |
|
50.3 |
|
46.3 |
Exceptional items (a) |
14.9 |
|
12.4 |
|
32.0 |
|
35.9 |
Other add-backs (b) |
0.6 |
|
2.7 |
|
5.8 |
|
6.4 |
Adjusted EBITDA |
129.3 |
|
139.4 |
|
249.4 |
|
261.7 |
|
|
|
|
|
|
|
|
Revenue |
746.9 |
|
753.1 |
|
1,507.0 |
|
1,536.8 |
Adjusted EBITDA margin (c) |
17.3 % |
|
18.5 % |
|
16.5 % |
|
17.0 % |
|
|
(a) |
Adjustment to add back exceptional items. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(b) |
Represents the elimination of share-based payment charges including employer payroll taxes for the three month period to |
(c) |
Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by Revenue. |
Reconciliation of Non-IFRS Financial Measures (continued)
Reconciliation from reported to organic revenue growth/(decline)
The following table is a reconciliation of reported revenue growth to Organic Revenue Growth for the three and six month periods ended
Year on Year Growth -
|
|||
|
Three Months Ended |
|
Six months ended |
|
YoY change |
|
YoY change |
Reported Revenue Growth |
(0.8) % |
|
(1.9) % |
|
|
|
|
Of which: |
|
|
|
Organic Revenue Growth |
(1.1) % |
|
(2.4) % |
Translational FX (a) |
0.3 % |
|
0.5 % |
Total |
(0.8) % |
|
(1.9) % |
|
|
(a) |
Translational FX is calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process. |
Forward-Looking Statements
Forward-Looking Statements and Disclaimers
Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including the Company's expectations regarding (i) its future operating and financial performance, including its 2025 guidance with respect to organic revenue growth, Adjusted EBITDA growth, adjusted free cash flow conversion, Adjusted EPS, and Adjusted EPS growth; (ii) disruptions in consumer behaviors, (iii) its growth initiatives, including with respect to its innovation and renovation initiatives, (iv) its ability to generate superior shareholder returns; (v) its bottom-line growth and cash generation; and (vi) its portfolio's ability to remain well positioned for consumer trends.
These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in
No Offer or Solicitation
This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law.
The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nomad-foods-reports-second-quarter-2025-financial-results-302522614.html
SOURCE